![](/img/cover-not-exists.png)
775PTrastuzumab and pertuzumab added to neoadjuvant chemoradiotherapy in resectable HER2+ esophageal adenocarcinoma patients: An update on survival and predictive biomarkers in the TRAP study
Stroes, C I, Creemers, A, Bennink, R J, Schokker, S, Verhoeven, R H A, Meijer, S L, Krisnadath, K K, van Oijen, M, Creemers, G-J, van der Sangen, M J C, Beerepoot, L V, Heisterkamp, J, Los, M, SlingerVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz247.101
Date:
October, 2019
File:
PDF, 78 KB
2019